Increased demand globally for immunity boosting products against the backdrop of the COVID-19 pandemic saw sales at Bayer Consumer Health’s Nutritionals category leap ahead by a third in the first quarter.
Sales of Nutritionals – which Bayer defines as multivitamins and dietary supplements – advanced by 32% to €351m ($382m) in the opening three months of 2020 as turnover from the